Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience

NCT03804554 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT03804554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03804554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
October 3, 2018
Completion date
August 12, 2021
Enrollment
503 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer